Omeros Corporation (OMER)

[surf1944]

7:04AM Omeros announces FDA acceptance of Omidria as proprietary name for OMS302 (OMER) 42.81 : Co reports the FDA accepted the proposed brand name Omidria for OMS302, the co's proprietary product in development for use in intraoperative lens replacement surgery. FDA's acceptance of the proprietary brand name is subject to the Agency's final determination prior to any approval of the product's New Drug Application and market launch, expected in 2014. Omeros earlier received allowance of the trademark application for Omidria from the U.S. Patent and Trademark Office.